Adenoviral Vector COVID-19 Vaccines: Process and Cost Analysis

October 2021

BY

Neal GordonManaging Director, Bioprocess Technology Group

Rick StockDirector, Bioprocess Technology Group

A cost of goods analysis provides valuable information at all stages of biologics product development. Early on, understanding the cost of goods will drive the selection of a technology platform and manufacturing scale that aligns with the intended market opportunity and pricing strategy. Through development, a cost of goods analysis can identify the major cost drivers and can be used to direct manufacturing process cost reduction efforts where needed.

The following scientific article highlights the BioProcess Technology Group’s use of the SuperPro Designer software and its application to estimating COVID-19 vaccine production costs for vaccine production technology behind the Oxford/AstraZeneca and J&J COVID-19 vaccines.